Medical cannabis patients at ‘low risk’ of hospitalisation from mental disorders – study

[Simple Jack]

Medical cannabis patients at ‘low risk’ of hospitalisation from mental disorders – study

Medical cannabis is not associated with an increased risk of psychiatric hospitalisations.

New data, published in the journal of Substance Use & Misuse, has concluded that medical cannabis patients are at low risk of psychiatric hospitalisations as a result of their consumption.

Researchers assessed cannabis-related hospitalisations among a cohort of over 23,000 authorised medical cannabis patients in Canada.

Canada has legalised the use of cannabis products for both medical purposes and for adult use.

Investigators tracked incidences of hospitalisations attributable to either “cannabis poisoning” or because of “mental or behavioural disorders due to the use of cannabis.” 

Patients in the study were tracked for a median of 240 days.

During the course of the trial, investigators reported that a total of 14 patients were hospitalised for issues related to cannabis toxicity and 26 were admitted for either mental or behavioural disorders. 

The findings push back against claims from some cannabis reform opponents that frequent cannabis exposure is a trigger for psychosis and other mental health disorders.

While some studies on illicit cannabis have linked use in adolescence to an increased risk of psychosis and schizophrenia in those thought to be predisposed to these conditions, there is as of yet little data on the risk of medicinal cannabis.

Self-administered, ‘recreational cannabis’ generally contains higher levels of THC and is consumed differently to how medical cannabis would normally be prescribed.

The authors of the study say they hope the findings will help “address concerns” around the use of medical cannabis.
 

They stated: “The results suggest that the incidence of cannabis poisoning or cannabis-related mental or behavioural disorders was low among patients who were authorised to use cannabis for medical care,” authors concluded. 

“Our observation of small rates of ED visits and hospitalisation for cannabis poisoning and CUDs [cannabis use disorders] among this large cohort of medical cannabis users helps address concerns regarding increasing use of medical cannabis.”

 

https://cannabishealthnews.co.uk/2022/08/15/medical-cannabis-patients-low-risk-of-mental-disorders-story22/

[Newcouch]

thanks.

what they dont say, wltjough they llink to it, is that the number of 14 cannabis toxicities is a lower number than should be expected since it links to synthetic spice.

synthetic spice casues most 'cannabis' toxicity, and there has been a reduction in this due to the availability of medical and nomral cannabis.

[twigs]

‘medica cannabis’ good

 

‘illicit cannabis’ baaad!  

 

the difference?, pharmaceutical profits!

 

cannabis for sick kids, really really good

 

cannabis for kids on the street, really really baaad!  

 

like the cannabis or the brain knows it’s medical or recreational  

 

..lost in their own propaganda..

 

meanwhile, proven, highly addictive, toxic pharma drugs dishout like sweets to everyone! all day every day, encouraged even by the medical profession! (profits)

 

 

 

 

 

 

[DrewHaynes]

This data can serve as a valuable resource for policymakers, healthcare providers, and patients as they navigate the complex landscape of medical cannabis.

[DrewHaynes]

For those interested in exploring related topics further, I recommend checking out https://www.mentalhealth.com/therapy/the-duty-of-confidentiality-for-mental-health-professionals.
In conclusion, this study contributes to our understanding of the safety profile of medical cannabis and underscores the importance of continued research in this field to ensure that patients receive the best possible care.